| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
116 Accumulation of HIV-1 Gag and Gag-Pol processing intermediates in the presence of non-peptidomimetic HIV-1 protease inhibitors
|
|
|
2000
|
46 |
1 |
p. A71-
1 p.
|
artikel
|
| 2 |
13 A comparison of the SCID-hu retinal implant and thy/liv implant models for determining the efficacy of antiviral therapies against human cytomegalovirus replication
|
|
|
2000
|
46 |
1 |
p. A39-
1 p.
|
artikel
|
| 3 |
43 A continuous time-resolved fluorescence assay for human immunodeficiency virus reverse transcriptase to determine enzymatic mechanisms of resistance
|
|
|
2000
|
46 |
1 |
p. A48-
1 p.
|
artikel
|
| 4 |
107 Activity of Zn-finger inhibitors against the arenaviruses junin, tacaribe and pichinde
|
|
|
2000
|
46 |
1 |
p. A66-
1 p.
|
artikel
|
| 5 |
152 A flow cytometric assay system for determining antiviral drug efficacy against lymphotropic herpesviruses
|
|
|
2000
|
46 |
1 |
p. A82-
1 p.
|
artikel
|
| 6 |
64 Age related differences in virus titers in patients in influenza trials of oseltamivir, a novel oral influenza therapy
|
|
|
2000
|
46 |
1 |
p. A54-
1 p.
|
artikel
|
| 7 |
34 A highly potent NNRTI possessing potential dual activity against HIV-1 reverse transcriptase and a post-attachment intermediate
|
|
|
2000
|
46 |
1 |
p. A45-
1 p.
|
artikel
|
| 8 |
17 4-alkoxy-substituted 1-benzyl-2-phenyl-benzimidazoles as NNRTIS: Synthesis and biological activity
|
|
|
2000
|
46 |
1 |
p. A41-
1 p.
|
artikel
|
| 9 |
111 Alkylglycerol foscarnet analogs active against drug-resistant HIV-1 are orally bioavailable in mice
|
|
|
2000
|
46 |
1 |
p. A70-
1 p.
|
artikel
|
| 10 |
120 Anatomical distribution of HSV-1 during antiviral chemotherapy
|
|
|
2000
|
46 |
1 |
p. A73-
1 p.
|
artikel
|
| 11 |
61 A new class of cyclopentane derivatives with potent inhibitory activity against influenza A and B viruses in cell culture
|
|
|
2000
|
46 |
1 |
p. A53-
1 p.
|
artikel
|
| 12 |
94 Anti-HBV and HIV activities of Chinese herb Qing Yang Can (QYC)
|
|
|
2000
|
46 |
1 |
p. A63-
1 p.
|
artikel
|
| 13 |
67 Anti-hepatitis B specific β-L-2′-deoxynucleosides
|
|
|
2000
|
46 |
1 |
p. A55-
1 p.
|
artikel
|
| 14 |
126 Antiherpetic activity and mode of action of 2-thio-5-alkyl-pyrimidine nucleoside analogues
|
Mori, S
|
|
2000
|
46 |
1 |
p. A76-
1 p.
|
artikel
|
| 15 |
19 Anti-HIV-1 activity of a novel nonnucleoside reverse transcriptase inhibitor of HIV-1 (SJ3366 a pyrimidinedione analog) used in combination with other inhibitors of HIV-1 replication
|
|
|
2000
|
46 |
1 |
p. A42-
1 p.
|
artikel
|
| 16 |
21 Anti-HIV-1 activity of PMEA, PMPA (9-(2-phosphonylmethoxypropyl)adenine) and AZT against HIV-1 subtypes A, B, C, D, E, F, G and O
|
|
|
2000
|
46 |
1 |
p. A42-
1 p.
|
artikel
|
| 17 |
83 Antiinfluenza and anti-HSV activity of the aminocaproic acid derivative acemin
|
|
|
2000
|
46 |
1 |
p. A60-
1 p.
|
artikel
|
| 18 |
113 Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques
|
|
|
2000
|
46 |
1 |
p. A70-
1 p.
|
artikel
|
| 19 |
11 Antiviral activity of D- and L-enantiomers of cyclohexenyl guanine
|
|
|
2000
|
46 |
1 |
p. A38-
1 p.
|
artikel
|
| 20 |
140 Antiviral activity of different anti-herpesvirus compounds on keratinocyte organotypic cultures infected with herpes simplex virus and varicella-zoster virus
|
|
|
2000
|
46 |
1 |
p. A79-
1 p.
|
artikel
|
| 21 |
91 Antiviral activity of β-L-thymidine and β-L-2′-deoxycytidine in the woodchuck model of chronic hepatitis B infection
|
|
|
2000
|
46 |
1 |
p. A62-
1 p.
|
artikel
|
| 22 |
151 Antiviral activity of the Non-nucleoside analogue CMV423 in lymphoblast cells infected with human herpesvirus 6
|
|
|
2000
|
46 |
1 |
p. A82-
1 p.
|
artikel
|
| 23 |
22 Antiviral amino acid carbamate derivatives of AZT
|
|
|
2000
|
46 |
1 |
p. A42-
1 p.
|
artikel
|
| 24 |
134 Antiviral susceptibility of penciclovir resistant mutants derived from herpes simplex virus type 1 in various cell lines
|
|
|
2000
|
46 |
1 |
p. A78-
1 p.
|
artikel
|
| 25 |
75 A pharmacodynamic evaluation of a murine model of influenza predicts efficacy for once daily dosing of RWJ-270201, a novel neuraminidase inhibitor
|
|
|
2000
|
46 |
1 |
p. A58-
1 p.
|
artikel
|
| 26 |
92 Ara-A-5′-phenyl methoxy alaninyl phosphate as a prodrug of the adenine arabinoside -monophosphate: synthesis and anti viral evaluation
|
Ballatore, Carlo
|
|
2000
|
46 |
1 |
p. A63-
1 p.
|
artikel
|
| 27 |
125 A thio derivative of 5′-noraristeromycin: Enantiomeric synthesis and biological properties
|
|
|
2000
|
46 |
1 |
p. A75-
1 p.
|
artikel
|
| 28 |
70 Cellular pharmacology of β-L-thymidine (L-dT, NV-02B) and β-L-2′-deoxycytidine (L-dC, NV-02C) in HepG2 cells and primary rat, monkey and human hepatocytes
|
|
|
2000
|
46 |
1 |
p. A56-
1 p.
|
artikel
|
| 29 |
136 Characterization of acyclovir-resistant herpes simplex virus collected by the task force on herpesvirus resistance
|
|
|
2000
|
46 |
1 |
p. A78-
1 p.
|
artikel
|
| 30 |
80 Characterization of an influenza A virus variant selected in vitro in the presence of the neuraminidase inhibitor, GS4071
|
|
|
2000
|
46 |
1 |
p. A60-
1 p.
|
artikel
|
| 31 |
146 Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase
|
|
|
2000
|
46 |
1 |
p. A81-
1 p.
|
artikel
|
| 32 |
155 Chimeric yellow fever 17D-Japanese encephalitis (ChimeriVax™-JE) vaccine: Preclinical effectiveness and safety testing in rhesus monkeys
|
|
|
2000
|
46 |
1 |
p. A84-
1 p.
|
artikel
|
| 33 |
145 Comparison of drug susceptibilities of clinical isolates of cytomegalovirus (CMV) for BAY43-9695, BAY38-4766 and ganciclovir (GCV)
|
|
|
2000
|
46 |
1 |
p. A80-
1 p.
|
artikel
|
| 34 |
69 Comparison of the anti-HBV activities of lamivudine, adefovir, famciclovir, lobucavir, and emtricitabine against wild-type and lamivudine-resistant HBV polymerases in vitro
|
|
|
2000
|
46 |
1 |
p. A56-
1 p.
|
artikel
|
| 35 |
Corporate sponsors
|
|
|
2000
|
46 |
1 |
p. A7-A8
nvt p.
|
artikel
|
| 36 |
63 Cross resistance of influenza virus mutants to NA inhibitors: Zanamivir, GS4071, and RWJ-270201
|
|
|
2000
|
46 |
1 |
p. A54-
1 p.
|
artikel
|
| 37 |
135 Cross susceptibility patterns and neuro-virulence of acyclovu-resistant herpes simplex virus (HSV) isolates collected in a national surveillance study
|
|
|
2000
|
46 |
1 |
p. A78-
1 p.
|
artikel
|
| 38 |
66 Dendrimers. Novel antiviral structures
|
|
|
2000
|
46 |
1 |
p. A55-
1 p.
|
artikel
|
| 39 |
58 Design, synthesis and activity of substituted pyrrolidine influenza neuraminidase inhibitors
|
Zhao, C.
|
|
2000
|
46 |
1 |
p. A53-
1 p.
|
artikel
|
| 40 |
128 Design, synthesis and evaluation of new antiviral nucleosides
|
|
|
2000
|
46 |
1 |
p. A76-
1 p.
|
artikel
|
| 41 |
142 Development and validation of a PCR-based assay for the quantification of human cytomegalovirus (HCMV) DNA in samples of frozen whole blood, plasma, urine and semen and the employment of the assay in the development of the HCMV inhibitor 1263W94
|
|
|
2000
|
46 |
1 |
p. A80-
1 p.
|
artikel
|
| 42 |
153 Development of a moderate throughput assay using TaqMan PCR technology to identify inhibitors of human herpesvirus 8 (HHV-8)
|
|
|
2000
|
46 |
1 |
p. A82-
1 p.
|
artikel
|
| 43 |
105 Development of resistance to disoxaril in coxsackievirus B1 infected newborn mice
|
|
|
2000
|
46 |
1 |
p. A66-
1 p.
|
artikel
|
| 44 |
29 Different adamantane derivatives inhibit HIV-1 replication in vitro
|
|
|
2000
|
46 |
1 |
p. A44-
1 p.
|
artikel
|
| 45 |
28 Does the 2-methylthiomethyl substituent really confer high anti-HIV-1 activity to S-DABOs?
|
|
|
2000
|
46 |
1 |
p. A44-
1 p.
|
artikel
|
| 46 |
Editorial Board
|
|
|
2000
|
46 |
1 |
p. ii-
1 p.
|
artikel
|
| 47 |
106 Effect of 6-Azacytidine to experimental adenoviral infection
|
|
|
2000
|
46 |
1 |
p. A66-
1 p.
|
artikel
|
| 48 |
114 Effects in macaques of SHIV infection and HAART on the expression of P-gp and cellular kinases
|
Jorajuria, S.
|
|
2000
|
46 |
1 |
p. A70-
1 p.
|
artikel
|
| 49 |
38 Effects of ADA on intracellular nucleoside triphosphate pools and implications for use in combination therapy
|
|
|
2000
|
46 |
1 |
p. A46-
1 p.
|
artikel
|
| 50 |
133 Effects of guanosine nucleoside analogues on cell death during HSV infection in vivo and in vitro
|
|
|
2000
|
46 |
1 |
p. A77-
1 p.
|
artikel
|
| 51 |
154 Efficacy of 2-amino-7-[1,3-dihydroxy-2-propoxy)methyl]purine for the treatment of vaccinia (orthopox-) virus infections in mice
|
|
|
2000
|
46 |
1 |
p. A83-
1 p.
|
artikel
|
| 52 |
25 Electrostatic potential surfaces of nucleosides and nucleotides: Correlations with inhibitors of HIV reverse transcriptase
|
|
|
2000
|
46 |
1 |
p. A43-
1 p.
|
artikel
|
| 53 |
14 Emergence of ganciclovir-resistant cytomegalovirus disease among solid organ transplant (SOT) recipients
|
|
|
2000
|
46 |
1 |
p. A39-
1 p.
|
artikel
|
| 54 |
2 Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV-1
|
|
|
2000
|
46 |
1 |
p. A35-
1 p.
|
artikel
|
| 55 |
99 Establishment of a cell based assay for evaluation of compounds against HCV NS2-3 protease activity
|
|
|
2000
|
46 |
1 |
p. A64-
1 p.
|
artikel
|
| 56 |
115 Expression and function of P-glycoprotein in HIV-linfected patients receiving protease inhibitor
|
|
|
2000
|
46 |
1 |
p. A71-
1 p.
|
artikel
|
| 57 |
108 Extracts from stevia rebaudiana is a potent anti-rotavirus inhibitor in vitro and in vivo
|
|
|
2000
|
46 |
1 |
p. A67-
1 p.
|
artikel
|
| 58 |
Final program
|
|
|
2000
|
46 |
1 |
p. A11-A33
nvt p.
|
artikel
|
| 59 |
First author index — Abstract number
|
|
|
2000
|
46 |
1 |
p. A88-A89
nvt p.
|
artikel
|
| 60 |
Fourteenth international conference on antiviral research
|
|
|
2000
|
46 |
1 |
p. A86-A87
nvt p.
|
artikel
|
| 61 |
Future conferences
|
|
|
2000
|
46 |
1 |
p. A85-
1 p.
|
artikel
|
| 62 |
82 Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor RWJ-270201
|
|
|
2000
|
46 |
1 |
p. A60-
1 p.
|
artikel
|
| 63 |
48 Genotypic and phenotypic analysis of HIV-1 from patients experiencing virological failure while on combination therapy containing two nucleoside reverse transcriptase inhibitors (NRTIs) and the NNRTI, emivirine (EMV, MKC-442): 48 week follow up
|
|
|
2000
|
46 |
1 |
p. A49-
1 p.
|
artikel
|
| 64 |
137 Herpes simplex virus type 1 (HSV-1) variants arising after selection with an antiviral carrageenan
|
|
|
2000
|
46 |
1 |
p. A78-
1 p.
|
artikel
|
| 65 |
40 High cellular uptake of lipophilic oligonucleotide prodrugs
|
Imbach, J.-L.
|
|
2000
|
46 |
1 |
p. A47-
1 p.
|
artikel
|
| 66 |
7 Highly polar, water-soluble prodrugs of the HIV protease inhibitor amprenavir: A new approach toward a more compact dosing regimen
|
|
|
2000
|
46 |
1 |
p. A37-
1 p.
|
artikel
|
| 67 |
42 HIV drug resistant quasispecies analysis in plasma, PBMC and viral isolates from HAART experienced patients
|
|
|
2000
|
46 |
1 |
p. A47-
1 p.
|
artikel
|
| 68 |
8 HIV-1 RT mutations in patients after 24 weeks of tenofovir disoproxil fumarate (formerly PMPA prodrug) therapy
|
|
|
2000
|
46 |
1 |
p. A37-
1 p.
|
artikel
|
| 69 |
5 Importance of stereochemistry in the design and selection of resistance mutations to D4-nucleosides
|
|
|
2000
|
46 |
1 |
p. A36-
1 p.
|
artikel
|
| 70 |
3 Increased pyrophosphorolysis of mutant HIV RT enzymes correlates with decreased processivity
|
|
|
2000
|
46 |
1 |
p. A36-
1 p.
|
artikel
|
| 71 |
12 Inhibition of cellular cyclin-dependent kinases as a possible mechanism of action for pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
|
|
2000
|
46 |
1 |
p. A39-
1 p.
|
artikel
|
| 72 |
117 Inhibition of herpes simplex virus (HSV) entry by a non-homologous peptide
|
|
|
2000
|
46 |
1 |
p. A72-
1 p.
|
artikel
|
| 73 |
6 Inhibition of HIV-1 replication by the Cre-loxP hammerhead ribozyme
|
|
|
2000
|
46 |
1 |
p. A36-
1 p.
|
artikel
|
| 74 |
45 Inhibition of HIV reverse transcriptase inhibitor- and protease inhibitor-resistant molecular clones of HIV by the biological response modifier, Ampligen
|
|
|
2000
|
46 |
1 |
p. A48-
1 p.
|
artikel
|
| 75 |
74 Inhibition of influenza neuraminidases by RWJ-270201: Mechanistic analysis and comparison to zanamivir and GS4071
|
|
|
2000
|
46 |
1 |
p. A58-
1 p.
|
artikel
|
| 76 |
102 Inhibition of measles virus replication by 5′-nor carbocyclic nucleoside analogs
|
|
|
2000
|
46 |
1 |
p. A65-
1 p.
|
artikel
|
| 77 |
98 Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir
|
|
|
2000
|
46 |
1 |
p. A64-
1 p.
|
artikel
|
| 78 |
119 Inhibitors of cellular cyclin-dependent kinases as antivirals
|
|
|
2000
|
46 |
1 |
p. A73-
1 p.
|
artikel
|
| 79 |
68 Inhibitory activity of new nucleoside analogs on wild type and YMDD mutants of the hepadnavirus reverse transcriptase
|
|
|
2000
|
46 |
1 |
p. A56-
1 p.
|
artikel
|
| 80 |
31 Intermolecular interactions of the Pr55gag polyprotein and the processed matrix and capsid proteins of HIV-1
|
|
|
2000
|
46 |
1 |
p. A45-
1 p.
|
artikel
|
| 81 |
36 Intracellular metabolism of 3-methyl-cycloSal-d4TMP and 3-methyl-cycloSal-AZTMP: Same concept but different antiviral outcome
|
|
|
2000
|
46 |
1 |
p. A46-
1 p.
|
artikel
|
| 82 |
Introduction to sponsor
|
|
|
2000
|
46 |
1 |
p. A7-
1 p.
|
artikel
|
| 83 |
132 In vitro and in vivo activity of N,N′-bisheteryl derivatives of dispirotripiperazine
|
|
|
2000
|
46 |
1 |
p. A77-
1 p.
|
artikel
|
| 84 |
86 In vitro and in vivo anti-influenza A virus activity of antisense phosphorothioate oligonucleotides containing 2′ - O-methylnucleosides (Gap-ODNs)
|
|
|
2000
|
46 |
1 |
p. A61-
1 p.
|
artikel
|
| 85 |
41 In vitro cytotoxicity of adefovir (ADV) mediated by the human renal organic anion transporter 1 (hOAT1) is efficiently reduced in the presence of various nonsteroidal anti-inflammatory drugs (NSAIDs)
|
|
|
2000
|
46 |
1 |
p. A47-
1 p.
|
artikel
|
| 86 |
84 In vitro efficacy of 2,7-dialkylamino-[1,8]-naphthyridines against influenzaviruses A and B
|
|
|
2000
|
46 |
1 |
p. A61-
1 p.
|
artikel
|
| 87 |
104 In vitro inhibitory effects of combinations of picornavirus replication inhibitors
|
|
|
2000
|
46 |
1 |
p. A66-
1 p.
|
artikel
|
| 88 |
93 In vitro screening and mechanistic studies of anti-HBV compounds
|
|
|
2000
|
46 |
1 |
p. A63-
1 p.
|
artikel
|
| 89 |
62 In vivo influenza-inhibitory effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201
|
|
|
2000
|
46 |
1 |
p. A54-
1 p.
|
artikel
|
| 90 |
139 Keratinocyte organotypic cultures as a model for studying viral infections
|
|
|
2000
|
46 |
1 |
p. A79-
1 p.
|
artikel
|
| 91 |
90 β-L-2′-deoxynucleosides as potent anti-HBV agents (part II): Large-scale stereospecific syntheses of β-L-2′-deoxycytidine and β-L-thymidine
|
|
|
2000
|
46 |
1 |
p. A62-
1 p.
|
artikel
|
| 92 |
89 β-L-2′-deoxynucleosides as potent anti-HBV agents (part I): Large-scale stereospecific synthesis of β-L-2′-deoxyadenosine
|
|
|
2000
|
46 |
1 |
p. A62-
1 p.
|
artikel
|
| 93 |
1 L-enantiomers of 2′- and 3′-azido-2′,3′-dideoxy-5-fluorocytidine: Stereospecific synthesis and antiviral activity
|
|
|
2000
|
46 |
1 |
p. A35-
1 p.
|
artikel
|
| 94 |
88 β-L-Thymidine and β-L-2′-deoxycytidine are potent, selective and specific anti-hepatitis B virus agents
|
|
|
2000
|
46 |
1 |
p. A62-
1 p.
|
artikel
|
| 95 |
100 Mechanism of action study of ribavirin on surrogate hepatitis C animal virus—Bovine viral diarrhea virus
|
|
|
2000
|
46 |
1 |
p. A65-
1 p.
|
artikel
|
| 96 |
46 Mixed dose effect analysis of a biological response modifier (Ampligen) with 14 FDA-approved anti-HIV agents
|
|
|
2000
|
46 |
1 |
p. A48-
1 p.
|
artikel
|
| 97 |
72 Mutations in the woodchuck hepatitis B virus (WHV) genome that confer resistance to lamivudine and penciclovir
|
|
|
2000
|
46 |
1 |
p. A57-
1 p.
|
artikel
|
| 98 |
27 Naphthoquinones as antiviral agents
|
|
|
2000
|
46 |
1 |
p. A44-
1 p.
|
artikel
|
| 99 |
55 National cancer institute: Connections with commercial partners for technology development
|
Gabrielsen, B.
|
|
2000
|
46 |
1 |
p. A51-
1 p.
|
artikel
|
| 100 |
76 New approaches for the inhibition of influenza neuraminidase
|
|
|
2000
|
46 |
1 |
p. A59-
1 p.
|
artikel
|
| 101 |
56 NMSO3, a potent inhibitor of respiratory syncytial virus (RSV) infection in vitro and in vivo
|
|
|
2000
|
46 |
1 |
p. A52-
1 p.
|
artikel
|
| 102 |
54 Novasomes and sodium dodecyl sulfate (SDS) enhance the microbicidal efficacy of nonoxynol-9
|
|
|
2000
|
46 |
1 |
p. A50-
1 p.
|
artikel
|
| 103 |
59 Novel amino acid inhibitors of influenza neuraminidase
|
|
|
2000
|
46 |
1 |
p. A53-
1 p.
|
artikel
|
| 104 |
15 Novel and potent anti-EBV compound, L-I-OddU dependents it's activity on EBV thymidine
|
|
|
2000
|
46 |
1 |
p. A39-
1 p.
|
artikel
|
| 105 |
121 Novel bicyclic fluorescent nucleosides as potent and selective inhibitors of VZV
|
|
|
2000
|
46 |
1 |
p. A73-
1 p.
|
artikel
|
| 106 |
112 Novel peptides inhibit HIV-1 replication in SCID mice: Relevance of the SCID mouse model for human trials
|
|
|
2000
|
46 |
1 |
p. A70-
1 p.
|
artikel
|
| 107 |
96 Optimizing the detection of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA): A potential marker for assessing the effectiveness of antivirals
|
|
|
2000
|
46 |
1 |
p. A64-
1 p.
|
artikel
|
| 108 |
65 Oral oseltamivir in experimental human influenza B virus infection: Lack of resistance emergence
|
|
|
2000
|
46 |
1 |
p. A54-
1 p.
|
artikel
|
| 109 |
Organization and conference committee
|
|
|
2000
|
46 |
1 |
p. A5-A6
nvt p.
|
artikel
|
| 110 |
131 Orofacial herpes simplex virus type 1 (HSV-1) infection in mice: A model for herpes labialis
|
|
|
2000
|
46 |
1 |
p. A77-
1 p.
|
artikel
|
| 111 |
78 Oseltamivir treatment of experimental influenza A/Texas/36/91 (H1N1) virus infection in humans: selection of a novel neuraminidase variant
|
|
|
2000
|
46 |
1 |
p. A59-
1 p.
|
artikel
|
| 112 |
118 Particular characteristics of the anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl]guanine (A-5021)
|
|
|
2000
|
46 |
1 |
p. A72-
1 p.
|
artikel
|
| 113 |
148 Phenotypic and genotypic characterization of antiviral drug-resistant cytomegalovirus in transplant recipients
|
|
|
2000
|
46 |
1 |
p. A81-
1 p.
|
artikel
|
| 114 |
147 Phenotypic and genotypic resistance pattern of human cytomegalovirus isolates obtained from vitreous and urine samples of AIDS patients with CMV-retinitis
|
Vogel, J.-U.
|
|
2000
|
46 |
1 |
p. A81-
1 p.
|
artikel
|
| 115 |
141 Phospholipid prodrugs of antiviral nucleosides: Synthesis and activity of octadecyloxyethyl, -propyl and -butyl esters of ganciclovir phosphonoformate
|
|
|
2000
|
46 |
1 |
p. A79-
1 p.
|
artikel
|
| 116 |
20 Phosphorylation of anti-HIV nucleotides AZT, d4T and ddNTP by nucleoside diphosphate kinase
|
|
|
2000
|
46 |
1 |
p. A42-
1 p.
|
artikel
|
| 117 |
77 Pitfalls in the biochemical evaluation of influenza neuraminidase inhibitors
|
|
|
2000
|
46 |
1 |
p. A59-
1 p.
|
artikel
|
| 118 |
95 Preclinical evaluation of two human anti-HBV monoclonal antibodies in two animal models for HBV infection
|
|
|
2000
|
46 |
1 |
p. A63-
1 p.
|
artikel
|
| 119 |
9 Prevention of mucosal HIV transmission by topical anticellular substances that target the HIV-infected lymphocytes in seminal fluid
|
|
|
2000
|
46 |
1 |
p. A37-
1 p.
|
artikel
|
| 120 |
23 Quaternary ammonium salts inhibiting HIV replication in vitro
|
|
|
2000
|
46 |
1 |
p. A43-
1 p.
|
artikel
|
| 121 |
30 Recognition and inhibition of HIV integrase by novel dinucleotides
|
|
|
2000
|
46 |
1 |
p. A44-
1 p.
|
artikel
|
| 122 |
101 Ribavirin (RBV) represses guanylate nucleotide pools but elevates pyrimidine pools in mouse lymphoma ML1210 cells as measured by capillary electrophoresis (CE)
|
|
|
2000
|
46 |
1 |
p. A65-
1 p.
|
artikel
|
| 123 |
52 Sensitivity of HIV-1-susceptible immune cell targets to topical microbicides nonoxynol-9 (N-9), C31G, and sodium dodecyl sulfate (SDS)
|
|
|
2000
|
46 |
1 |
p. A50-
1 p.
|
artikel
|
| 124 |
44 Sensitivity of mutant HIV-1 rRT to DABOs
|
|
|
2000
|
46 |
1 |
p. A48-
1 p.
|
artikel
|
| 125 |
Social functions
|
|
|
2000
|
46 |
1 |
p. A9-
1 p.
|
artikel
|
| 126 |
53 Sodium dodecyl sulfate (SDS) and C31G as effective microbicidal alternatives to nonoxynol-9 (N-9): Comparative cytotoxicity in primary human vaginal keratinocytes
|
|
|
2000
|
46 |
1 |
p. A50-
1 p.
|
artikel
|
| 127 |
10 Spiropentane analogues of nucleosides: Chemistry and antiviral activity
|
|
|
2000
|
46 |
1 |
p. A38-
1 p.
|
artikel
|
| 128 |
149 Structure-activity relationships of (E)-5-(2-bromovinyl) uracil and related pyrimidine L-Nucleosides as antiviral agents for varicella zoster virus
|
|
|
2000
|
46 |
1 |
p. A81-
1 p.
|
artikel
|
| 129 |
39 Structure-activity relationship studies of nucleoside analogs with anti-HIV activity using structure-activity maps
|
|
|
2000
|
46 |
1 |
p. A47-
1 p.
|
artikel
|
| 130 |
81 Studies on the mechanism by which mutations at His274 alter sensitivity of influenza A virus neuraminidase type 1 to GS4071 and zanamivir
|
|
|
2000
|
46 |
1 |
p. A60-
1 p.
|
artikel
|
| 131 |
144 Suppression of constitutive NF-κB activity in cytomegalovirus infected retinal glial cells inhibits virus replication and virus-induced upregulation of interleukin 8
|
Margraf, Stefan
|
|
2000
|
46 |
1 |
p. A80-
1 p.
|
artikel
|
| 132 |
35 Suppression of TNF-α- and HIV-1 gp120-induced neural cell death by an anti-inflammatory alkaloid, cepharanthine
|
|
|
2000
|
46 |
1 |
p. A46-
1 p.
|
artikel
|
| 133 |
122 Surveillance for resistant herpes simplex virus type 1 (HSV-1): a collaborative survey in the US of the general population with recurrent herpes labialis
|
|
|
2000
|
46 |
1 |
p. A73-
1 p.
|
artikel
|
| 134 |
18 Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT inhibitors
|
Chimirri, A.
|
|
2000
|
46 |
1 |
p. A41-
1 p.
|
artikel
|
| 135 |
127 Synthesis, antiviral evaluation and structure activity relationships of novel 5-ethyl analogs of 2′-deoxyuridine, 1-β-D-arabinofuranosyl uracil and uridine
|
|
|
2000
|
46 |
1 |
p. A76-
1 p.
|
artikel
|
| 136 |
26 Synthesis of aminoacids derivatives as Rev-RRE binding inhibitors, using solid phase combinatorial chemistry
|
|
|
2000
|
46 |
1 |
p. A43-
1 p.
|
artikel
|
| 137 |
150 Synthesis, properties and anti-EBV activity of a new series of 3′-modified cycloSal-BVDUMP pronucleotides
|
|
|
2000
|
46 |
1 |
p. A82-
1 p.
|
artikel
|
| 138 |
33 Temacrazine inhibits initiation of HIV-1 transcription
|
|
|
2000
|
46 |
1 |
p. A45-
1 p.
|
artikel
|
| 139 |
110 Tenofovir exhibits a highly favorable profile in the experimental cell culture models for renal tubular toxicity
|
|
|
2000
|
46 |
1 |
p. A69-
1 p.
|
artikel
|
| 140 |
32 The activity of Mg2+ and poly r(A-U) against HIV-1
|
|
|
2000
|
46 |
1 |
p. A45-
1 p.
|
artikel
|
| 141 |
129 The antiviral activity exerted by vaccinia virus on the growth of herpes simplex virus in BS-C-1 cells
|
|
|
2000
|
46 |
1 |
p. A76-
1 p.
|
artikel
|
| 142 |
124 The dendrimer BRI2999 inhibits the early stages of herpes simplex viruses replication
|
|
|
2000
|
46 |
1 |
p. A75-
1 p.
|
artikel
|
| 143 |
130 The effect of famciclovir (FCV) on herpes simplex virus type 1 (HSV-1) corneal disease, latency and reactivation in the rabbit eye model
|
|
|
2000
|
46 |
1 |
p. A77-
1 p.
|
artikel
|
| 144 |
49 The evolution of HIV-1 resistance mutations in two French couples
|
|
|
2000
|
46 |
1 |
p. A49-
1 p.
|
artikel
|
| 145 |
60 The neuraminidase inhibitor oseltamivir is efficacious against A/Hong Kong/156/97 (H5N1) and H9N2 influenza viruses
|
|
|
2000
|
46 |
1 |
p. A53-
1 p.
|
artikel
|
| 146 |
109 The novel NNRTI SJ-3366 inhibits HIV-1 through multiple mechanisms of action: Effects on reverse transcriptase and virus attachment
|
|
|
2000
|
46 |
1 |
p. A69-
1 p.
|
artikel
|
| 147 |
97 The recombinant HBV baculovirus as an improved model for the in vitro assessment of antihepadnaviral compounds
|
|
|
2000
|
46 |
1 |
p. A64-
1 p.
|
artikel
|
| 148 |
71 The trimera mouse system: A model for HCV infection and evaluation of antiviral drugs
|
|
|
2000
|
46 |
1 |
p. A56-
1 p.
|
artikel
|
| 149 |
51 The vaginal environment: studying parameters which influence microbicide cytotoxicity
|
|
|
2000
|
46 |
1 |
p. A50-
1 p.
|
artikel
|
| 150 |
24 Total synthesis of the natural products Inophyllum B, Cordatolide A, B and their analogues 11-demethyl Cordatolide A and B. Non-nucleoside inhibitors of HIV-1 reverse transcriptase
|
|
|
2000
|
46 |
1 |
p. A43-
1 p.
|
artikel
|
| 151 |
123 Transformation of human vaginal xenografts by human papillomavirus type 11: Prevention of infection with a microbicide from the alkyl sulfate chemical family
|
|
|
2000
|
46 |
1 |
p. A74-
1 p.
|
artikel
|
| 152 |
50 Treatment naïve HIV-1 infected patients respond immunologically when administered HE2000; results from a phase I/II clinical trial
|
|
|
2000
|
46 |
1 |
p. A49-
1 p.
|
artikel
|
| 153 |
37 Treatment of human T-lymphoid cell lines with pharmacological relevant cytarabine concentrations results in decreased CD4 expression and reduced HIV-1 susceptibility
|
|
|
2000
|
46 |
1 |
p. A46-
1 p.
|
artikel
|
| 154 |
47 Unusual resistance profile of conocurvone, an early-stage inhibitor of HIV-1 replication
|
|
|
2000
|
46 |
1 |
p. A49-
1 p.
|
artikel
|
| 155 |
103 Use of cotton rats for preliminary testing of potential measles virus antivirals
|
|
|
2000
|
46 |
1 |
p. A65-
1 p.
|
artikel
|
| 156 |
85 Utilization of alpha 1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors
|
|
|
2000
|
46 |
1 |
p. A61-
1 p.
|
artikel
|
| 157 |
73 Viral dynamics analysis of HBV clearance under different antiviral treatment regimens using a mathematical model
|
|
|
2000
|
46 |
1 |
p. A57-
1 p.
|
artikel
|
| 158 |
4 Viral entry as the primary target of anti-HIV activity of chicoric acid and its tetra-acetyl esters
|
Pannecouque, C.
|
|
2000
|
46 |
1 |
p. A36-
1 p.
|
artikel
|
| 159 |
79 Virological assessment in vitro and in vivo of an influenza H1N1 virus with a H274Y mutation in the neuraminidase gene
|
|
|
2000
|
46 |
1 |
p. A59-
1 p.
|
artikel
|
| 160 |
143 Virological, clinical, and ophthalmologic features of cytomegalovirus chorioretinitis after hematopoietic stem cell transplantation
|
|
|
2000
|
46 |
1 |
p. A80-
1 p.
|
artikel
|
| 161 |
138 Virus replication in brain tissues of mice infected intracerebrally with a avirulent drug-resistant mutant of HSV-1
|
|
|
2000
|
46 |
1 |
p. A79-
1 p.
|
artikel
|
| 162 |
57 VP14637: A sub-nanomolar inhibitor of respiratory syncytial virus
|
|
|
2000
|
46 |
1 |
p. A52-
1 p.
|
artikel
|
| 163 |
16 1263W94 inhibits the phosphorylation of EBV DNA polymerase processivity factor BMRF1 by EBV protein kinase BGLF4
|
|
|
2000
|
46 |
1 |
p. A40-
1 p.
|
artikel
|
| 164 |
87 XTT and WST-1 — two highly sensitive tetrazolium reduction assays for screening of anti-influenza agents in MDCK cells
|
|
|
2000
|
46 |
1 |
p. A61-
1 p.
|
artikel
|
Tijdschrift beschrijving